Skills to Learn While Unemployed to Make Yourself More Employable

As somebody who has been unemployed more than once, unemployment can be depressing, very frustrating and extremely worrisome.  In addition to sending out resumes and networking, I highly recommend using the free time that you have at your disposal to learn new skills to either make your life more manageable or to increase your employability.  Obviously, unemployed persons usually don’t have the money to enroll in formal training programs but thanks to the Internet and social media there are a variety of free tools and options out there for people looking to pick up new skill sets. 

Amber Johnson at OnlineDegreePrograms.org has put together a list of 100 skills you should learn (for free) while unemployed. While many of her suggestions are intuitive, there are a few on the list that may surprise you and quite possibly improve your chances of finding a new job!

100 Skills You Should Learn (for Free) While You’re Unemployed

People Skills and Networking

Become a better networker, small talker and listener to improve your job prospects.

  1. Listen: Become a better listener by tuning out background noise and making eye contact.
  2. Build a portfolio: Have an organized hard copy and file on your computer that succinctly and accurately represents your best work.
  3. Share the conversation: Don’t dominate the conversation: learn to take a step back when you’ve said your part, and know when to jump in if the conversation becomes all about them.
  4. Understand your emotional intelligence: Become more socially aware and learn to evaluate your own emotions and reactions.
  5. Bring personality to a company: Being able to provide something that people can relate to behind the big corporate name is priceless.
  6. Make your resume Internet ready: Make sure your updated resume will display nicely when you e-mail it and post it on job sites.
  7. Set an example: Learn how to inspire others by doing what you love, being expressive, and helping others along the way.
  8. Expand your network: Tap into contacts two or three degrees removed from your regular network.
  9. Network or interview on the phone: Stop working on your in-person networking skills for a minute and remind yourself how to win someone over via the telephone.
  10. Give a strong handshake: Impress people with your confidence by giving a better handshake.
  11. Remember people’s names: From face association to repetition, there are various ways to remember a person’s name.
  12. Know when and how to use icebreakers: Become the one other people depend on to make connections and feel comfortable.
  13. Make a point to grow existing relationships: Don’t just get to know people on the surface: get to know business and personal contacts on a deeper level.

Life hacks

From making your own coffee to saving gas, here you’ll learn valuable skills that save you money, too.

  1. Make your own coffee: Cut back on expensive coffee runs by learning how to make your own cup.
  2. Comparison shop: Comparison shopping will save you money and turn you into a more responsible consumer and better product researcher.
  3. Learn how to be more energy efficient: Save money on energy bills at home and at your new office when you get hired again.
  4. Save gas: Minimize the number of times you have to spend money on gas by making each fill up last longer.
  5. Eat cheaply: Watch this video to learn how to make yummy meals out of dollar-store food.
  6. Discover your life purpose: Discover how to tap into your life purpose and passion to give you more direction in your job search and life goals.
  7. Face reality: Accepting and dealing with reality will help your career and your personal life.
  8. Cook: While you have the time, learn to cook healthy, budget-friendly meals for yourself, and use leftovers.
  9. Being positive: Stop complaining and turn yourself into a positive thinker.
  10. Meditate: Meditation will help get you through the tough times.

Productivity and Task Mastering

Stay productive and learn to stay on task, avoid procrastinating and set goals even when you’re unemployed.

  1. Get up on time: Learn how to get up right when your alarm goes off to get a fresh, productive start to the day.
  2. Funneling: The art of funneling means that you know how to manage incoming projects and to-do lists, and prioritize them accordingly.
  3. Speed reading: You’ll be able to stay on top of industry reports, news stories, job postings and more when you learn to speed read.
  4. Break things down: Turn difficult tasks into easier ones by breaking them down and taking it day by day.
  5. How to set goals: Setting goals will help you be more successful, in the short-and long-term.
  6. Overcome fear of failure: Fear of failure wastes time and prevents you from doing what you really want.
  7. Beat procrastination: This step-by-step guide will help you beat procrastination.
  8. Prepare a to-do list: A well-organized to-do list will keep you on track and save time.
  9. Learn the Pomodoro Technique: Those who are anxious about meeting deadlines should master this technique.
  10. Eliminate distractions: Learn how to tune out distractions and interruptions.

Computer and Internet Skills

These skills will turn you into a better Googler, blogger and typer.

  1. Online research: Besides helping you find a job, solid Internet research skills will make you a desirable job candidate.
  2. Learn how to use different operating systems: Train yourself to learn how to use Macs, Windows and Linux systems.
  3. Hack Google: Learn all of the Google shortcuts and business tools.
  4. Build a high-traffic website: Promote yourself and show potential employers how you can improve their websites.
  5. Use Facebook productively: Turn Facebook into a business tool for networking, branding and more.
  6. Basic web design: Employers will snatch you up if you know even basic web design.
  7. Blog: Becoming an expert blogger takes time, so use your unemployment to learn the technical and business side of blogging.
  8. Telecommute: Learn how to work with others online.
  9. Learn to type: Typing quickly and correctly saves you time and makes your work look more professional.
  10. Create a podcast: This fun and simple skill could increase your job prospects too.

Organization

Organize your personal and professional life by learning these skills.

  1. Be punctual: Being punctual forces you to map out your day according to appointments and to-dos.
  2. Use spreadsheets: Spreadsheets are great organizing tools and are used at almost every office.
  3. Sort email: Set up folders, archives, filters and searches to organize all of your emails.
  4. Prioritize: Prioritize your tasks so that it’s easier to work down your to-do list.
  5. Use a calendar: Make use of an online calendar to set up alerts and more tools to help you stay organized.
  6. Improve your memory: Practice different techniques to improve your memory.
  7. Organize your closet: A better organized closet will help you stay on top of chores and get ready faster in the mornings.

Writing

Write better emails, use better grammar and influence others with your writing.

  1. Write better emails: Write effective, impressive emails and subject headings.
  2. Learn correct grammar: Poor grammar will hurt your career prospects in a heartbeat.
  3. Persuasive writing: Learn how to write more persuasively and passionately.
  4. Write for the Internet: Writing online pieces is completely different than writing for traditional media.
  5. Write the perfect cover letter: Write a better opening and remember to include all the important details.

Confidence

These skills will boost your confidence and make others take notice of you.

  1. Work on body language: Learn how to stand confidently, make eye contact and relax.
  2. Trust yourself: If you’re constantly worried about what other people think of you and your decisions, you’ll come across as weak and inexperienced.
  3. Examine your soft skills: Discover what soft skills make you a good employee: leadership, dedication, or the ability to motivate others.
  4. Master the job interview: Be prepared, be confident and research the company and person you’re interviewing with.
  5. Handle rejection: Stay confident and inspired even when you aren’t getting call backs.

Promotion and Branding

The skills you learn to promote yourself now will pay off later.

  1. Design for branding: Learn how to think creatively and visually in order to promote your brand.
  2. Understand copyright: Learn about copyright laws and how to get your own patent.
  3. Promote yourself without bragging: You’ve got to learn how to relate to people and make them interested in you and your experience, without bragging.
  4. Know — and own — your best attributes: Show off your ability to close a sale or put on your resume that you’re the one to call if a decision needs to be made.
  5. Being accountable: Monitor what’s being said about you online and on social networks, keep track of your brand’s reputation, and own up to any mistakes or issues people have with you.
  6. Use Twitter effectively: Learn how to use Twitter to boost your brand and reputation, not diminish it.
  7. Develop your message: Learn how to create a focused, engaging message.
  8. Write a press release: Even if you don’t work in PR or marketing, being able to write a press release is a valuable, desirable skill personally and professionally.
  9. Follow up: Make sure you follow up on promises and after meeting new people.
  10. Identify an audience: Learn how to rework your message depending on who you’re speaking to.

Speaking and Communication

From better storytelling to learning a new language or becoming an effective public speaker, these communication skills will make you more influential and confident.

  1. Learn a foreign language: Speaking at least two languages greatly increases your desirability as a job candidate.
  2. Storytelling: For presentations and networking, it helps if you’re a good storyteller.
  3. Keep it simple: Don’t babble; instead, learn to speak clearly and simply.
  4. How to make transitions: Making smooth transitions in your talks and presentations will strengthen your speech overall.
  5. Deliver bad news: You should learn how to be diplomatic and break bad news considerately.
  6. Consider things from different points of view: Relate to your audience and act like a fair leader by considering various points of view.
  7. Give a compliment: If you’re uncomfortable giving compliments, you’d better learn how to get over it.
  8. Negotiate: Negotiate salary, job offers, payment, and more.
  9. Conflict management: Learn how to be more diplomatic and solve problems in the workplace.
  10. Speak to executives: Don’t be afraid to talk to the boss, just make sure you do it the right way.

Finance

Save money and learn smarter budgeting tips here.

  1. Open a Roth IRA: Use a little of the money you have saved to start a Roth IRA for the future.
  2. Pay taxes as a freelancer: If you’re freelancing between full-time jobs, you’ll need to learn how to do your own taxes.
  3. Turn eBay into a money-maker: While you’re out of work, learn how to use eBay to make extra cash.
  4. Haggle: Get better deals on food, entertainment, clothes and more when you learn to haggle.
  5. Lower your cell phone bill: Learn how to lower your cell phone bill when you’re tightening your budget.
  6. Get a tax extension: If you just can’t pay your taxes this year because you’re unemployed, learn how to get an extension.
  7. Consolidate debt: This skill may help you with a finance problem at work and alleviate some of the burden of high interest rates.
  8. Make a budget: This practical skill will save you money and help you trim expenses at work.
  9. Find a bargain: Learn when to go generic and hunt for bargains.
  10. Save: Practice restraint by setting up savings accounts and spending less.

Weird Skills

You never know when you’ll need to win a fist fight or have to know your tolerance for alcohol, so practice now.

  1. Win a fist fight: Man up and learn how to win a fist fight or street fight.
  2. Be more photogenic: Look more attractive and confident in photographs.
  3. Know your tolerance: Before getting wasted at networking events or office parties, know how much booze you can handle.
  4. Be a respectful house guest: Review basic etiquette and send a thank-you note the next day.
  5. Know when someone is lying: Be able to tell when someone else is lying to protect yourself.

Miscellaneous

From tying a tie to taking better notes, here are more skills you should learn while you’re unemployed.

  1. Stay on top of industry news: Make reading industry reports and niche news blogs a habit for when you’re unemployed and when you get a job.
  2. Get comfortable with international travel: Even if you can’t afford a plane ticket, read world news, learn a language and keep up with other cultures to broaden your horizons and show potential employers that you’re open to traveling for them.
  3. Tie a tie: Make sure you always look presentable by tying your tie correctly.
  4. Keep your brain active: Keep learning so that you’re in shape to tackle new challenges when you do find a job.
  5. Take better notes: Learn to take notes during interviews and meetings.

There you have it!

Until next time...

Good Luck and Good Job Hunting!!!!

Conference Round Up: e-Patient Connections 2009

e-Patients Connections 2009 (#epatcon) was held this past Monday and Tuesday at the Park Hyatt hotel in Philadelphia, PA. BioCrowd was one of several co-sponsors of the event. The theme of the conference, organized by Kevin Kruse a veteran medical communication and training expert, who now runs Kru Research, was to “reach, engage and educate empowered digital health consumers.” And, boy, did it deliver! While this was Kru Research’s first official conference, it was well organized, extremely interactive and the quality of the speakers was second to none! Topics that were featured included social media and the life sciences industry, technological advances in e-based healthcare delivery, the relationship between the news media and healthcare information and the continuing evolution of online and e-based healthcare communities.

Conference attendees included representatives from the life sciences industry, medical communications experts, advertising and marketing professionals and a multitude of social media enthusiasts and consultants who kept the Twitter screen humming throughout the meeting (a big shout out to the “troublemaking table”). And, surprisingly, there was a representative from the Division of Drug Marketing and Advertising and Communications (DDMAC) at the US Food and Drug Administration, who I believe, was one of the most sought after individuals at the meeting. CNN reporter Elizabeth Cohen who writes the Empowered Patient and racecar driver Charles Kimball, a type I diabetic and company spokesperson for Novo Nordisk also gave talks.

My favorite talks were those presented by online patient community organizers including Tricia Geoghegan of Ortho-McNeil-Janssen Pharmaceuticals who created the Facebook ADHD Allies community, Lisa Tate of WomenHeart and Robert Schumm of Bayer Consumer Care who created Facebook Strong@ Heart and Rachel Lewinson of the Juvenile Diabetes Research Organization and Susan Harrow Rago of Novo Nordisk who created Juvenation.org a website dedicated to those with Type I diabetes. These communities are outstanding examples of how partnerships between pharmaceutical companies and advocacy groups can help to better educate the public and heighten awareness about potentially life-altering diseases. Another example of a great online community and healthcare portal is Insomnia 123.com. This website was conceived and constructed by Christine Macadams and her partners’ one of whom is a practicing physician. Unlike the other online communities, which are sponsored and mainly supported by consumer healthcare division of large pharmaceutical companies, Insomnia 123.com was exclusively created by a group of concerned individuals who wanted to better educate and improve the lives of people with insomnia—a largely unreported and self-medicated condition.

On the technical side, the talks presented by Lee Segal of Klick, Kevin Durr of Avantera , Ian Kelly of Red Nucleus and Scott Ballenger of ListenLogic were illuminating and extremely informative. Some of the innovations taking place in digital media are exciting and almost overwhelming at times (even for a social media enthusiast like me). I think the company to watch is ListenLogic which uses semantic search engines to collect real time data and “chatter” on the web. This technology may provide a cost-effective solution to assuage the concerns of many life sciences companies that claim that collecting and analyzing overwhelming amounts of data is one of the main reasons why they are reluctant to entry the social media space.

Marc Monseau of Johnson and Johnson gave an illuminating talk on his experiences as a corporate blogger and Twitter user and described some of the challenges that had to be overcome before his company was able to break the “social media barrier.” Janice McCallum, an economist by training and a healthcare communications and media expert gave an informative talk about the growing role and impact of patient-generated healthcare content on patient awareness and education.

Finally, the novel and innovative Pecha Kucha sessions were outstanding and extremely well done! While all were expertly crafted, Dr. Val’s and Jonathan Richman’s Pecha Kucha were memorable. Dr. Val’s, which was extremely powerful and moving, was performed entirely in verse and Jonathan’s was—well, one of Jonathan’s always entertaining and informative presentations.

In summary, the “e-Patient Connections 2009” was a resounding success and in my opinion reached its goal to “reach engage and educate empowered digital health consumers.” That said, I can’t wait for “e-Patient Connections 2010” meeting!!!

Hat tip to @ellenhoenig and @eileenobrien for inviting me to my first tweetup (great fun) and finally meeting @janice McCallum, @christianeTrue, @stevewoodruff and Silja aka @whydotpharma

Until next time...

Good Luck and Good Job Hunting!!!!!!!

 

Social Media: Pharma's Continuing Web 2.0 Inertia

I came across a recent post on Adage.com entitled “Pharma Drops Search Advertising After FDA Warning” that revealed that paid search ads by pharmaceutical companies dropped a 84% between March 26 of this year and the end of June. As you may recall, March 26 was when 14 companies received warning letters from the US Food and Drug Administration (FDA) indicating that they had violated marketing guidelines for search ad advertising. The letters stated that sponsored-link advertisements for specific drugs were misleading due to the exclusion of risk information associated with the use of the drug -- even though the regulatory agency's guidelines are for print and broadcast, not online or social media. Pharma companies that believed they were in compliance with the unwritten "one-click rule"— taking the consumer from the ad to a site that offered fair balance and the risk information by clicking on the ad. What? Did I read that correctly; the words “unwritten and FDA” in the same sentence? This is very surprising since anybody who has worked with the agency is well aware of the “if it isn’t written it didn’t happen” principle. But I digress....

The post went on to say that pharmaceutical companies are “fearful of running afoul” of the agency again. Say what? The words “pharma and fearful” used in the same sentence? The point that I am trying to make is that pharma chose to keep things vague about web-based advertising to see how far they can push the envelope with FDA instead of taking the proverbial “bull by the horns” and directly asking FDA for guidance on web 2.0 technologies and their uses. Wouldn’t it be in everyone’s best interest if companies took a more active role to help craft new rules on the use of new media technologies rather then rely on and wait for FDA to do it for them? While the old “cat and mouse” game worked for old media, it is no longer tenable when it comes to Web 2.0 and related technologies.

The FDA is holding public hearings next month to begin the process of establishing internet advertising guidelines and the use of social media in the life science industry. This offers drug and devices companies an opportunity to show FDA that they no longer want to be part of the problem but part of the solution.  I have always subscribed to the notion that “you don’t get if you don’t ask!”

Until next time...

Good Luck and Good Surfing (on the Internet that is)

 

blog comments powered by Disqus

 

Upcoming Conference on Social Media and Digital Health

For the first time in history, more people are searching the Internet for health information than asking doctors. Web 2.0 and social media tools are allowing people to discover new ways to connect, learn and engage one other in search of healthcare and drug information.

e-Patient Connections 2009 which will be held in Philadelphia, PA on  October 26 and 27 will feature a number of leading authorities on social media and digital health  Some of the featured speakers include Wired Magazine’s Thomas Goetz, Jay
Bernhardt of the CDC, and Lee Aase of the Mayo Clinic. The conference also offers case studies, 1:1 coaching sessions with industry experts and the latest products from digital health companies.

BioJobBlog readers can use the discount code kru500 to save $500 off the current price.

See you there!

 

Social Media: DNA Videos Rock

While pharmaceutical and biotechnology companies have been reluctant to use social media, Bio-Rad, Applied BioSystems and other life sciences reagent and instrumentation companies have jumped on the YouTube video train with reckless abandon.

A quick perusal of the molecular biology-related videos on YouTube reveals several scintillating titles like “Do the Double Helix,” “DNA Replication Rap,” and my personal favorite from Bio-Rad, “The PCR Song” (see video below)

 

 

Until next time....

Good Luck and Good Watching !!!! 

SocialTwist Tell-a-Friend

 

FDA to Begin Considering Guidance on the Use of Social Media in the Life Sciences Industry

Mark Senak at the EyeonFDA blog reported yesterday that the US Food and Drug Administration (FDA) is seeking public input on the use of social media in the pharmaceutical, biotechnology and medical devices/diagnostic industry. Meetings to solicit input will be held in Washington DC on November 12 and 13th.  This will be the first opportunity for industry representatives and the public to begin a discussion with FDA on the policies that will guide the use of social media in the life sciences industry.

According to EyeonFDA, on Monday, the agency will publish a notice in the Federal Register announcing this historic event (see excerpt below)

Questions have arisen regarding the application of the prescription drug and device advertising and labeling provisions, regulations, and policies of promotion on the Internet, especially with regard to the use of emerging technologies such as blogs, microblogs, podcasts, social networks and online communities, video sharing, widgets, and wikis. This section briefly discusses the issues the agency has identified as most frequently raised by regulated companies and other interested parties. It should be noted that although a question may raise a particular issue, that does not necessarily mean that the agency will issue guidance or a regulation on that issue. The agency invites comment at the public hearing on the general concept of Internet promotion, positive or negative; on any aspect of Internet promotion that is of interest to the presenter; and on the topics outlined in the following paragraphs. We are specifically interested in data and research on the use of social media tools in promotion, including data from companies on their own experiences, the extent to which health care professionals and consumers are using and are influenced by various social media tools, and the impact of Internet and social media promotion on the public health.

For the past year or more, many bloggers and other social media enthusiasts have taken FDA to task for not taking action on the topic. Finally, the agency realized that something had to be done given the growing use and popularity of social media tools and strategies in other less regulated industries. Earlier this week, in an unexpected move, FDA launched its first Twitter feed. Perhaps this was a hint that FDA is beginning to emerge from the dark ages into the digital world of Web 2.0 and social media.

Hat tip to Mark!

Until next time...

Good Luck and Good Twittering !!!!!!!

SocialTwist Tell-a-Friend

 

FDA is on Twitter?????

Mark Senak who runs the EyeonFDA blog reported yesterday that the US Food and Drug Administration (FDA) had launched a Twitter account. As Mark aptly points out, FDA’s unexpected leap into social media is ironic given that the agency has been steadfastly reluctant to craft any guidance whatsoever on the use of Web 2.0  technology or social media by drug and device manufacturers. Maybe, the agency was tired of being overshadowed by the Centers for Disease Control in Atlanta, GA whose rapid adoption and use of social media for public health and related issues has been outstanding. 

For those of you FDA aficionados, FDA can be found on Twitter at @FDA_Drug_Info. Despite its very recent launch, the agency already has over 1,700 followers. Not surprisingly, FDA_Drug_Info is following only six individuals and is largely a one-way informational channel. Maybe somebody ought to tell the agency that social media, most notably Twitter, is suppose to be interactive and conversational? Also, couldn’t FDA staffers come up with a better Twitter handle? I mean the use of underlines to separate words in FDA_Drug_Info is so ......Web 1.0!!!! Finally, most of the information tweeted by the agency has to do with drug approvals, workshop announcements, safety warnings, etc. Maybe somebody also should tell them that most life sciences companies block Twitter and other forms of social media. Nevertheless, based on some recent tweets, it appears that the agency is targeting healthcare providers and consumers as their main audiences.

Despite FDA’s Twitter presence, I wouldn’t expect any Web 2.0 guidance or a drug and device social media policy any time soon. I say this because the agency yet to craft guidance on website design and Google Ads—two very ancient internet tools!!!! Maybe they ought to appoint a social media czar at the agency?

Until next time....

Good Luck and Good Tweeting!!!!

 SocialTwist Tell-a-Friend

Social Media: Why Life Scientists May be Missing Out on a Good Thing

I have previously written several posts on the reluctance of life scientists to use social media and online social networking sites. While I realize that scientists may be somewhat socially challenged, the almost universal disdain for social media is puzzling and troubling to me. More importantly, the reluctance of life scientists to embrace social media flies in the face of some revealing new statistics on social media use by the American lay public.

According to a recent survey by Forrester Research, “half of online adults now belong to social networks like, Facebook and Linked In, a 46 percent growth rate year-over-year.” More importantly, almost a quarter of Americans are content creators who write blogs, upload video or audio or post articles online.” Interestingly, the growth of social media is being driven by adults 35 and older. The survey found that four of five adults of all ages use social media including blogs, social networks and review sites. Finally, most adults visit social networking sites, in way or another at least monthly.

Many scientists who I have talked with (mostly graduate students and postdoctoral fellows) primarily use social media to stay in touch with friends or “hook up” with others after laboratory hours are over. And, other scientists—mostly laboratory heads and principal investigators—view social media as a colossal waste of time. Unfortunately, the scientists who underutilize or shun social media don’t understand its hidden potential to advance scientific research and perhaps more importantly to interact with the lay public to demystify “science.”  In my experience social media has been a powerful way to disseminate information and quickly reach large numbers of people. Isn’t this what science is really about?    

Until next time....

Good Luck and Good Job Hunting!!!!!!!!!!!!

 SocialTwist Tell-a-Friend

Case Study: Tweeting for Jobs

Twitter is arguably the hottest new platform to hit the social media scene is the past five  years. Twitter devotees are convinced that anything is possible if the microblogging platform is used correctly. In today’s economy, the most pressing need for many people is finding a job. While Twitter is effective for branding, marketing and occasionally some witty intellectual exchanges, its usefulness for jobseekers has yet to be demonstrated. To that end, there was a recent instructional case study on TwiTip—“5 Methods I Used To Get a Job Through Twitter”— that describes how Twitter can be used to find gainful employment. Although the case study focuses on non-science jobseekers, many of the suggestions and recommendations are relevant to those seeking jobs in the life sciences.

Read and learn!!!

Until next time...

Good Luck and Good Job Hunting!!!!!!

 SocialTwist Tell-a-Friend

 

Jobseekers and Employees: Be Careful What You Tweet!

The whole world is atwitter about Twitter (pun intended). One of the reasons why social media tools like Twitter are so effective is that information can reach very large audiences almost instantaneously.

While there are constitutional guarantees of free speech in the US and elsewhere, there are certain things that are safe to tweet and others that are not. This is especially true if you are corporate employee or a jobseeker looking for a new opportunity. While this ought to be intuitively obvious to most, younger and less well-experienced individuals may not know the “unwritten rules” pertaining to office workplaces and job searching.  To that end, there is a wonderful post on the Resume Bear website(@ResumeBear) that lists 20 things that jobseekers and employees should never say on Twitter.  Although some of the examples and recommendations are comical and funny, getting fired or not getting a job because of something you might have said on Twitter isn’t. 

Until next time....

Good Luck and Good Job Hunting!!!!!!!!!!

 SocialTwist Tell-a-Friend

 

Podcast: Putting Social Media to Work for Pharma

Lisa Roner, blogger and editor for EyeforPharma, recommends a podcast on social media that was created by Dr. Andree Bates, CEO at Eularis, a company that applies analytics to determine the sales impact of specific marketing programs.

Dr. Bates says it is an important area for pharmas to become engaged in social media.  In the podcast, she offers some ideas about how pharma marketers might apply these channels effectively. Also, she offers some tips and hints for intrepid pharma employees who are interested in getting started.

To listen to the podcast click here.

Until next time...

Good Luck and Good Networking!!!!!!!!

 SocialTwist Tell-a-Friend

Why Bioscientists Aren't Warming to Social Media

BioCrowd co-founder, Vincent Racaniello, and I were chatting the other day with Crowdvine’s Tony Stubblebine (the guy who created the BioCrowd software platform) about the reluctance of scientists to embrace social media. Both Vincent and I, both scientists ourselves, posited that scientists are simply asocial or at the very least not comfortable engaging in social activities whether they be online or IRL. Tony, a self-anointed software geek, wasn’t buying into to our argument and noted that even software geeks are social!

This prompted me to do a little research and I found a blog post written by Nachiket Vartak a blogger and doctoral student at the Max Planck Institute for Molecular Physiology. While the blog post focused mainly on reasons why bioscientists won’t use Twitter, I think that many of his observations can be used to generally describe the chilly relationship between many scientists and social media. Before you read on, I must inform you that I paraphrased and embellished some of Nachiket’s original ideas on the subject. That said, here are some of the reasons why bioscientists may not use social media.

1. The reputation of social networking sites
Many scientists disdain social networks because they believe that social networking sites and microblogging platforms like Twitter are nothing more than places to waste time. Those scientists who use social media usually do it in-between experiments and when planning activities which usually involve copious quantities of alcohol, for after laboratory hours fun. In other words, social media is for fun not for work. Also, many so-called serious scientists contend that “real science discussions” only happen on closed e-mailing lists or forums and not in the “open” on social networking sites.

2. The social activation barrier
According to Nachiket, the stereotype that scientists are asocial is well.....err...true! He asserts that many scientists feel more comfortable focusing on themselves (and their research) rather than interacting with others to learn what they have to say or what they may be thinking. And, many times, unless an individual can demonstrate that they are “smart” they probably aren’t worse listening to anyway. Finally, scientists train for years to become independent investigators. Not surprisingly, there is very little emphasis and importance placed on teamwork or social interactions with others scientists or lay people for that matter. Therefore, it should come as no surprise that many scientists aren’t particularly social or inclined to participate in extracurricular social activities.

3. Privacy aka “secrecy”
Science is a highly competitive endeavor and, in many cases, the discoveries that are made represent many years of sacrifice, blood, sweat and tears. With this in mind, nobody wants to be scooped or beat out by their competitors. Consequently, scientists are generally instructed to be very hush-hush when it comes to sharing any information or data that might give the competition a “leg up” in the competition. Any leak, large or small, could mean the difference between fame and failure and, perhaps more importantly, a successful career as a scientist.

In marked contrast, the success of social media is contingent upon its openness, sharing and transparency. Thus, as Nachiket aptly pointed out social media is antithetical to the very nature of science and scientists.

4. Legitimate channels of communication
The only acceptable and legitimate means of scientific communications are presentations at meetings and publications in peer reviewed journals. These forms of communication are the lifeblood of scientific community and critical to the success of all scientists. If you aren’t published, you have no credibility as a scientist. The scientific publishing and communication industry is big business and “the rules of engagement” in the industry have been well established and institutionalized. Unfortunately, social media threatens to destabilize the science publishing world both financially and philosophically and possibly change the way science information is communicated. Therefore, it should come as no surprise that there is little support for social media in scientific publishing world and the science community in general.

While the number of science blogs and podcasts continue to increase daily, scientific social networking sites continue to struggle. This is because the information flow in blogs and similar forms of social media can be easily monitored and controlled. This is not the case for social networking sites like BioCrowd and microblogging platforms like Twitter.
However, if scientists are truly asocial beings then none of the existing science social networking sites will gain traction and be successful. Call me crazy, but I think social networking is an ideal medium for scientists to exchange information, ideas and develop relationships that can help them jumpstart their careers!

Until next time...

Good Luck and Good Networking!!!!!!!!!!


 SocialTwist Tell-a-Friend

Building A Social Networking Site for Bioprofessionals

At the recent Social Communication and Healthcare conference I was invited to run a roundtable discussion entitled “How to Build a Social Networking Site for Bioprofessionals.” The discussions were well attended, primarily by employees several pharmaceutical companies and vendors who sell scientific equipment and reagents. Several bloggers and medical communications professionals also attended.

While microblogging platforms like Twitter are slowly supplanting traditional networking sites as the social medium of choice, themed online communities like BioCrowd--hich was exclusively designed for bioprofessionals ranging from scientists to venture capitalists—are still useful for jobseekers and people who are interested in a “richer” networking experience. For those of you who are interested in social networking sites, I wrote a brief synopsis of the two roundtable discussions that I conducted.

Please feel free to contact me with any additional thoughts, ideas or comments you may have about the piece.

 Until next time...

 

 Good Luck and Good Networking!

  

 SocialTwist Tell-a-Friend

Adverse Event Reporting, Social Media and Pharma

Pharmaceutical,biotechnology and other companies that sell prescription drugs and devices are deathly afraid of adverse events (AEs) associated with their products. For those of you who may not know, companies with approved prescription drugs and medical devices are required to track and report any adverse events associated with their products to regulatory agencies like the US Food and Drug Administration (FDA). If FDA receives enough AE complaints about a product, the agency will investigate to determine whether or not there may be efficacy, safety or tolerability issues with it. And, if FDA thinks that the AEs are legitimate, it may ask a company to conduct Phase IV clinical trials with the product in question or require that changes be made to the product’s label. Not surprisingly, these outcomes can be time consuming and perhaps more importantly, costly. Label changes—especially for blockbuster products—frequently lead to changes in physician prescribing habits which can translate into a loss of revenue. Despite the fact that ALL drugs exhibit AEs, many companies falsely cling to the hope that there will be few, if any, AEs reported for their products.

While drug makers are very familiar with the range of possible AEs associated with their drugs—all AEs for a drug are identified and reported during clinical trials—pharmaceutical executives are concerned about social media activities, because they fear that than the number and frequency of AEs reported for their products will increase. This, in turn, would prompt FDA and other regulatory agencies to investigate and more closely scrutinize their marketed products. As Jonathan Richman, author of the Dose of Digital Blog points out in an excellent post entitled the “Myth of Adverse Event Reporting” AEs are a fact of life for prescription drugs. And, that social media may help to improve adverse reporting. Like Jonathan, I contend that social media might allow drug makers to more effectively identify potential safety issues with a product earlier in its lifecycle and thereby minimize possible deleterious effects of the drug on certain patient populations. I think that drug manufacturers ought to begin to consider how they might effectively use social media to improve AE reporting rather than ignore the potential upside of this new medium.

The Myth of Adverse Event Reporting

Adverse Events are nothing more than negative reviews. If you want people to genuinely talk about your brand, they are going to say negative things. But how often do posts include adverse events? Nielsen decided to take a look at this rather than simply assume it was ” a lot,” which of course is a difficult number to manage. Nielsen looked at Yahoo Health boards and took 500 postings. Of these, only 1 contained enough information to qualify as an adverse event that needed to be reported. That’s 0.2%. Why so low? Turns out that someone simply saying that your drug caused them to have a headache isn’t enough to qualify as an adverse event. Nielsen summed up the pieces of information required to report an adverse event and there are four pieces: “(i) an identifiable patient; (ii) an identifiable reporter; (iii) a specific drug or biologic involved in the event; and (iv) an adverse event or fatal outcome.” (Hat tip to Pharma 2.0 for the summary). The study showed that one or two of these pieces were often available, but not all four. In addition, they found that it would be impossible to get all four even with some effort. In fact, the FDA says, “[Without these pieces] a report on the incident should not be submitted to the FDA because reports without such information make interpretation of their significance difficult, at best, and impossible, in most instances.”

This is because people often don’t register or leave their personal information in a post, so there is no way for a company to follow up and fill in the blanks. Naturally, if there is something significant, every effort should be made, but on the often anonymous Internet, this is usually difficult. Suppose for a moment there were several adverse events that need to be reported. How often do they need to be reported? The FDA is pretty clear on this. For new drugs, reports need to be filed quarterly for three years. After that, it’s annually. For “serious and unexpected” events, these have to be reported within 15 days. However, there’s a pretty high threshold for an adverse event to be considered “serious and unexpected.” Every company already has these reporting channels in place, so it is simply a matter of including adverse events received from social media into the workstream. 

Yes, it’s a balance. The fact is adverse events should not be the reason why healthcare shies away from social media. These risks can easily be mitigated and, if done right, can actually be used in a positive way. So, don’t use adverse events as an excuse anymore. You’ve got the data. 1 in 500 posts include a reportable event. You report quarterly at most (which you’re doing anyway). How much ongoing effort do your other marketing programs require? Probably quite a bit more than this. Next time you hear this excuse, you’ve got the data to dispel the myth of adverse event reporting.

Until next time...

Good Luck and Good Job Hunting!!!!!!

 SocialTwist Tell-a-Friend

Social Media and Pharmacovigilance

Mark Senak, author of the EyeonFDA blog and social media enthusiast, posted a great piece about pharma’s reluctance to adopt social media and the changes in adverse event reporting-- aka pharmacovigilance--requirements that may change this attitude. 

Hat tip to Mark!

Until next time...

Good Luck and Good Job Hunting

 SocialTwist Tell-a-Friend

The Who's Who of Social Media, Pharma and Healthcare

I met Jonathan Richman,the author of the Dose of Digital blog, last week at the BDI Conference (#BDI) on Social Communication and Healthcare in NYC. BTW, for those of you who were unable to attend, you missed an informative and compelling meeting on the status of social media in the pharmaceutical and healthcare industries. Anyway back to Jonathan. He gave a great talk on pharma and social media which prompted me to visit his blog. While perusing Dose of Digital, I came upon a wiki that Jonathan maintains called --what else-- the Pharma and Healthcare Social Media Wiki.” 

It’s a comprehensive, cataloged list of social media initiatives underway at pharma, biotech and healthcare industries. Noticeably absent from the wiki, are social networking sites like BioCrowd that were specifically created for life scientists and other bioprofessionals. Hey, wait a minute, aren’t scientists the lifeblood of the life sciences industry? Would there be a life sciences industry without scientists? Hmmmm....I will have to talk to Jonathan about this!

I highly recommend you check out the wiki if you are a life sciences social media enthusiast!

Until next time...

Good Luck and Good Social Media Hunting!!!!!  

 SocialTwist Tell-a-Friend

NYC Social Media and Healthcare Conference Update

The “Social Media and Healthcare” conference that will be held on July 23, 2009 in NYC at the Graduate Center of The City University of NY (365 Fifth Avenue at 34th Street) is shaping up to be a great one. At present, over 350 people have registered for the meeting. There are a few slots left if you are interested in attending.

Several BioJobBlog readers have asked whether or not the sessions will be recorder and available online. Steve Etzler, one of the conference organizers told me that Blogtalkradio.com will broadcast and archive the audio from all of the case studies that will be presented during the morning sessions. Unfortunately, the round table discussions won’t be available.

As I may have mentioned, Cliff Mintz, Co-Founder of BioCrowd will be leading a roundtable discussion entitled “Building Social Networking Sites for Bioprofessionals.”

See you on Thursday!!!

Until next time....

SocialTwist Tell-a-Friend

NYC BioBuzz: Social Media and Healthcare Meeting on July 23, 2009

BioJobBlog and BioCrowd along with the Business Development Institute, the Journal of Communication in Healthcare and others are co-sponsoring a meeting entitled “Social Media and Healthcare” that will be held on July 23, 2009 in NYC at the Graduate Center of The City University of NY (365 Fifth Avenue at 34th Street). Topics that will be covered include:  

  1. Managing regulatory and legal issues when planning and implementing social media strategies
  2. Is there a role for social media in President Obama’s healthcare reform plans?
  3. Why real-time social media tools like Twitter are gaining momentum and when it makes sense to use them
  4. How social media has affected crisis communications in the healthcare industry
  5. Selling social communications projects and proving ROI to senior management
  6. Creating and participating in communities to achieve communication, educational and branding objectives
  7. Planning and executing a social communications plan with little or no budget
  8. Building relationships and partnerships with new healthcare media leaders beyond advertising
  9. Best practices for using social communications to connect internally with employees and stakeholders
  10. Tools, technologies, and best practices for monitoring and measuring social communications

The meeting’s agenda features case study presentations and a series of roundtable discussions on social media topics. I will be leading a roundtable discussion called “How to Build a Social Networking Site for Bioscientists.” Approximately 300 senior marketing, communications and media professionals from Fortune 1000, middle market and emerging growth companies are expected to attend from leading pharmaceuticals, medical technology/device companies, managed care providers, hospitals, healthcare media companies, government and nonprofit organizations.  

BioCrowd members can register for the meeting at a discounted rate of $155. Check it out—it will be money well spent!

Hat tip to Steve Etzler at the BDI and Mario R. Nacinovich Jr., Editor-in-Chief, Journal of Communication in Healthcare for organizing this topical and important meeting.

I hope to see you at the meeting next Thursday!!!!

 

SocialTwist Tell-a-Friend

 

FDA Update: A Sleeping Giant Is Showing Signs of Life

Mark Senak, who writes the outstanding Eye on FDA blog, posted an interesting article today that tracks the number of warning letters issued by DDMAC (the center that oversees life sciences marketing and advertising) over the past 12 years. Not surprisingly, the number of warning letters issued by DDMAC fell precipitously during the Bush Administration, after reaching a high during the waning years of Bill Clinton’s presidency. In fact, the number of warning letters issued by DDMAC during the first two quarters of 2009 exceeds the yearly total of warning letters issued in the past 4 of five years. However, as Mark clearly points out, the 2009 year to date number of warning letters may be artificially inflated because of 14 identical ones issued on the same day (April 2) to 14 different companies regarding internet search engine advertising. Nevertheless, it is becoming increasingly apparent that the agency is beginning to emerge from a long slumber and that US regulatory oversight may be entering a new, more scrutinizing era. 

While increasing regulatory scrutiny may be appropriate after 8 years of no regulation at all, it is important that FDA doesn’t overreact and unnecessarily stifle new drug and product development. To that end, I believe that the agency needs to be reorganized, revamped and revitalized to replace its traditionally “reactive” way of doing business with a more “proactive” one.  For example, there is a burgeoning need for regulatory guidance on the use of social media by companies in the pharmaceutical, biotechnology and medical devices and diagnostics industries. Unfortunately, FDA has been unwilling or unable to enunciate a cogent regulatory strategy or any meaningful guidance on this topic. Consequently, many life sciences companies have refrained from using social media because they simply don’t know how to implement it in the current regulatory environment. I believe that FDA, not the companies it regulates, should take the lead on this issue.

Finally, it is becoming increasingly apparent that many companies will continue to refrain from using social media and other Web 2.0 tools until FDA crafts some useful guidance on these topics. Sadly, Web 3.0 is just around the corner and the agency is still struggling with regulatory guidance for corporate websites. Maybe Congress needs to craft some new FDA modernization legislation—it has been 12 years since the last modernization bill was passed!

Until next time....

Good Luck and Good Job Hunting!!!!!!!!!

 SocialTwist Tell-a-Friend

Social Media Manager--A New Career Option for PhD Life Scientists?

While life sciences companies are still reluctant to take the “social media plunge,” many other companies (with active social media programs) frequently hire employees known as social media managers who oversee and run their social networks.  This is because successful social media websites require daily attention and are extremely time consuming and labor intensive. In general, employees who are hired for these jobs have strong backgrounds in social media and technology but frequently possess little expertise in the industry that they are working in. Because social media is so new, many hiring managers believe that the social media and technology skills of these managers are more important than an understanding of the industry that they work in. However, while this practice may be acceptable in other industries, it won’t be the case for the social media managers who oversee pharmaceutical, biotechnology and medical devices and diagnostics social media websites. These managers will likely be required to have a firm understanding of current rules and regulations guiding drug development and marketing and advertising of approved life sciences products. This will be necessary if the drug makers who hire these managers want to steer clear of regulatory scrutiny by the US Food and Drug Administration and other regulatory agencies.

Based on my experiences as an industrial scientist and more recently as a social media manager, a person with a PhD degree with at least one course in regulatory affairs, good oral and written communication skills and an interest in social media ought to be an ideal candidate for these positions. To that end, those of you who may be interested in this newly, emerging career path option ought to begin training as soon as possible—these jobs will be in high demand at life sciences companies, medical communications agencies and conference organizers in the next year or so!

Until next time....

Good Luck and Good Job Hunting!!!!!!!!!!!!

 SocialTwist Tell-a-Friend

Social Media Internship at Science Magazine

I just learned from Diego Pineda who runs the Medical Writer Blog and Medical Writing social network about an interesting internship possibility at Science magazine. For those of you social media enthusiasts interested in the opportunity, here is a job description.

“Science, the world's leading journal of original scientific research and global news, seeks a three-month intern to help implement and manage social media projects for its news department. The candidate should be very familiar with Facebook, Twitter, and other social networking platforms, and should have experience creating content for these platforms. Other duties will include promoting news content on the internet, moderating comments on our daily news site, and repurposing news content for multimedia projects. Some writing and research assistance for our online news site is possible. The ideal intern will have a science background-or at least a strong interest in science-and some journalism experience. The internship will be at our Washington, D.C. headquarters.”

For consideration, send a resume and cover letter to AAAS, Human Resources Department, 1200 New York Ave., NW, Suite #101, Washington, DC 20005.  (Attn:  Requisition #1763) You may also reach us by Fax at 202-682-1630 and e-mail at jobs@aaas.org.

It appears that Science is finally getting into the social networking.  For those of you, who can’t wait for the Science network, please check out BioCrowd, a social networking community focused on career development for bioprofessionals.

Until next time....

Good Luck and Good Job Hunting!!!!!!!!!!!

 

SocialTwist Tell-a-Friend

Several Ways That Pharma Can Harness the Power of Social Media

The debate, if you can call it that, over whether or not interactive social media platforms like Facebook and Twitter can be used in the life science industry is moving forward at glacial speed. I decided that it was time to propose some ideas rather than continue to admonish the US Food and Drug Administration (FDA) for a lack of guidance.

There are several reasons which may explain the inertia surrounding the adoption of social media by pharmaceutical, biotechnology and medical devices and diagnostics companies. First, and perhaps foremost, FDA has been consistently reluctant to craft any useful guidance on the use of Web 2.0 technologies for research, clinical or promotional purposes. The FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC) is still trying to figure out how to regulate website content. Is it any wonder that FDA is reluctant to tackle the regulatory implications and issues associated with social media platforms like Facebook and Twitter? Second, a majority of social media advocates— who are leading the charge at many life sciences companies—are marketing and advertising executives who tend to look at social media strictly as a promotional tool. Finally, much of what takes place at life sciences companies is proprietary and confidential—information flow between the company and its employees and the public is fastidiously monitored and tightly regulated. Because of this, the life sciences industry’s “process” is intentionally opaque—which is contrary to the goals of social media which is to promote transparency (or the illusion of it).

There is no doubt that the life sciences industry is the most highly regulated industry on the planet. While this represents a formidable challenge for adoption of social media, it is by no means insurmountable—especially if social media is used for purposes other than branding, marketing and advertising. For example, the most straight forward application of social media at life sciences companies would be in the areas of corporate recruitment and employee retention. Many Fortune 500 companies outside of the life sciences industry have been using Facebook, MySpace and LinkedIn for years for recruiting purposes. While not commonly acknowledged, life sciences companies have quietly begun to use Facebook, LinkedIn and MySpace to recruit prospective employees. Interestingly, the new kid on the block—Twitter—looks to potentially be a more powerful recruiting tool than any of its predecessors. Unfortunately, employee retention is no longer a priority at many companies. However, before the economic meltdown a number of companies, most notably Best Buy, were experimenting with social media to retain talented employees.

Another potential use of social media is for pharmacovigilance and adverse events reporting. Companies with approved products on the market are required by FDA (and other regulatory agencies that approved their products) to set up post marketing surveillance programs for adverse events reporting. By law, companies that receive adverse events reports from consumers, physicians or other entities must report them to the regulatory agencies that approved the product. Regulatory agencies maintain adverse events databases for all approved drugs and devices to monitor drug safety.  If designed and implemented correctly, interactive social media platforms like Facebook and Twitter (which operates in real-time) would make excellent pharmacovigilance and adverse reporting tools. Quite coincidentally, John Mack, who runs the Pharma Marketing Blog, reported a partnership between UCB and PatientsLikeMe.com to create a pharmacovigilance reporting platform for UCB products.

Recruiting patients for participation in clinical trials (to assess efficacy and safety of prospective new drugs) has become extremely challenging over the past few years.Traditional patient recruitment strategies include print, television and radio ads and in some instances, websites. All of these recruitment methods are costly, labor intensive and limited in their effectiveness because they only reach small number of prospective clinical trial participants. I contend that Facebook with over 200 million users, LinkedIn with members in over 140 different countries and Twitter which is growing rapidly would be ideal for clinical trial recruitment and retention purposes. Others have also proposed this idea.

Finally, while the use of social media to promote approved drugs and devices may be difficult because of regulatory constraints, it can be utilized to keep the public informed about prospective new medicines and promote a company’s image or brand. There is no question that the public perception of the pharmaceutical industry has been severely tarnished over the last few years.  The industry’s continued lack of transparency and failure to adequately disclose potential safety risks about some approved products continues perpetuate a negative image. One way to restore public trust and confidence is to use social media to actively engage the public in conversation on wellness, addressing unmet medical needs and prospective new medicines and treatments that are being developed. Also, social media platforms could be employed to showcase community outreach programs and discuss educational initiatives to improve science education and training.

Social media is no longer a new phenomenon or technology. It is a legitimate form of communication which has become an integral part of the Web 2.0 experience. I suspect that the life sciences industry will have to make a decision about social media in the not so distant future—or possibly miss a potentially game-changing business opportunity. And, as Ken Kesey aptly said in Tom Wolfe’s ‘The Electric Kool-Aid Acid Test’—“You’re either on the bus…or off the bus.”

 Until next time...

 Good Luck and Good Job Hunting!!!!!!!!

 SocialTwist Tell-a-Friend

Pharma Flocking to Social Media?

Mark Sendak, a social media enthusiast and author of the Eye on FDA blog, wrote a great post today about an article he saw in the Washington Post entitled “Drug Firms Jockey for Space Online.”

Mark wrote: “Flock?  Flock?  FLOCK?  The only way you could use the term "flock" in connection with pharmaceutical firms and social media is to say that companies are a scared flock of geese.” He goes on to castigate FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC) for a lack of a coherent regulatory framework and guidance for the use of social media in the life sciences industry.

Mark aptly describes DDMAC’s guidance surrounding social media and the pharmaceutical industry this way. “No one knows, and DDMAC apparently makes this stuff up as they go along. That is the kind of Whack-a-Mole game DDMAC plays.  We won't tell you what is off limits, until you do it and then WHACK! Is this anyway to run a pharmaceutical industry?

I am in total agreement with Mark on this issue. Despite the rapid adoption of social media by other industries, FDA has consistently been reluctant to issue any regulatory guidance what so ever on the topic despite assertions to the contrary. Unfortunately, when it comes to social media and the pharmaceutical industry, FDA’s usual approach to regulatory guidance—reactive rather than proactive—is still alive and well. As you may recall FDA previously sent warning letters to no fewer than 14 pharmaceutical and biotechnology companies admonishing them on their placement of product ads on search engine results pages. The fact that 14 different companies received warning letters on this issue reflects the confusion and lack of guidance offered by FDA on social media and the use of Web 2.0 technologies to promote or support the sale pharmaceutical products.

The growing popularity and inevitability of social media suggests that DDMAC officials along with industry representatives must begin to consider crafting a preliminary regulatory framework for its use in the life sciences industry. Like it or not, social media is here to stay!

Hat tip to EyeonFDA!

Until next time....

Good Luck and Good Job Hunting

 SocialTwist Tell-a-Friend

 

Social Networks and Corporate Recruiting: Leveraging Employee Referrals to Find New Talent

The advent of social networking sites like MySpace, Facebook and Linked In have been a boon to recruiters and human resources (HR) professionals. Social networks represent a vast and easily-accessible source of job candidates whose professional credentials and personal information are readily available to determine whether or not they may be potential new hires. While the effectiveness of recruiters and HR professionals to source new talent is debatable, I contend that there is nobody more qualified than employees at a company to identify prospective new employees who may bring value to an organization. A number of forward-thinking companies have realized that the best way to find “right fit job candidates” is to mine the social networking contacts of their existing employees. To that end, Appirio and Jobvite, two San Francisco, CA-based start ups, developed software platforms that allow their clients to link employee social networks and candidate sourcing solutions to employee referral programs. 

A hiring company that uses Appirio’s application, ask its employees who belong to Facebook to add the application to their personal pages. When new jobs are available, Appirio’s matching engine searches the Facebook pages of an employee’s friends and uses job titles, geography and key words to determine which friends might be a good fit for the available positions. Once identified, a friend receives a referral from the employee inviting him/her to apply for the job (if interested). If the “friend” is ultimately hired, Appirio’s application allows the company to identify which employee found the match and offer a referral bonus. To address privacy concerns, the list of possible matches is available to only to friends/employees—not the hiring company or Appirio.

Jobvite offers a similar service but in addition to Facebook, it also searches and mines friend/contact information from Linked In and Twitter. And, anyone who receives a Jobvite referral can also search his/her own network to identify suitable job candidates and pass it along again. Jobvite recipients who are hired can be tracked to the original sender, so that the employee can receive a referral bonus—even if the Jobvite referral has been passed from one inbox to another up to six times.

Despite the explosion of job boards, social networking sites and social media tools like Twitter, employee referrals are still the most effective way for jobseekers to find new jobs. The Appirio and Jobvite solutions represent a novel way to leverage employee relationships to match jobseekers with prospective new employers. However, in this job market, I wouldn’t sit around and wait to receive an Appirio or Jobvite invitation from one of your social networking friends. Instead, I recommend that you put your social networking sites to good use and tell everyone you know that you are actively seeking employment.  Because at the end of the day finding a new job is all about networking!

Until next time...

Good luck and Good Job Hunting!!!!!!!!!!

 

SocialTwist Tell-a-Friend

Social Networks More Popular Than e-mail!!!

The New York Times reported today that for the first time, Internet users are spending more time on social networking and video sites than on e-mail. According to a report by Nielsen, there was a 1,905 percentage change in the time that users spent viewing online video and an 883 percentage increase in social networking use from February 2003 to 2009.

These changes represent something of a paradigm shift in consumer's relationship with the Internet. People are increasingly moving away from portal-oriented sites, like shopping directories to social networking sites like YouTube and Facebook and providers of niche content.

While marketers have yet to master advertising on social networking sites, Internet pundits and social media enthusiasts believe that over the next year or so a viable business model will emerge that is reliant on social networking user influence and opinions.

Until next time...

Good Luck and Good Networking!!!!!

 

MySpace vs. Facebook: No Contest?

When Rupert Murdoch, the owner of New Corporation (Fox News), bought MySpace for $580 million in 2005 it was viewed by many as one of his savviest acquisitions ever. At that time, MySpace was arguably the most successful social networking site on the Web and its financial future was extremely bright. Shortly after the acquisition, a young, upstart college social networking site called Facebook began operations without much fanfare. Back in 2005, MySpace had 14 million monthly users and Facebook was still raising capital. Now, MySpace has 126 million users whereas Facebook’s user base has grown to over 200 million. Facebook continues to expand while MySpace’s growth appears to be stagnant. This led to the dismissal last week of one of MySpace’s co-founders and the appointment of a former Facebook executive as CEO.

Since 2005, MySpace has generated about $1.6 billion in revenues and earned 200 million last year alone. However, it is important to note that a major portion of its operating capital comes from $900 million that Google guarantees every year. That agreement comes up for renewal next year and the likelihood of Google agreeing to the original terms is questionable. This is probably why Murdoch is shaking things up at MySpace. While it is likely that Google will attempt to renegotiate the terms of the original agreement, I seriously doubt that it will severe all financial ties with MySpace. That would be a bad business decision and Google doesn’t make many of those!

While many social networking pundits attribute Facebook’s ongoing success to its connectivity rather than its content, I still contend that “content is king” and social networking sites built around user-generated content are great investment opportunities. After all, status updates, pithy wall comments and photo tagging tend to “get old” quickly after a few months.

While the possible loss of Google’s annual cash infusion will hurt MySpace, I don’t think that MySpace is on its “deathbed” yet and rumors of its demise are premature. The social networking universe is vast and niche networks—not large unfocused ones—will ultimately prosper because of targeted advertising and other business opportunities. That said, I believe there will always be a place for MySpace in the social networking world.

Until next time...

Good Luck and Good Networking!!!!!!!!!! 

SocialTwist Tell-a-Friend

Social Media and Career Development for Life Scientists

Unlike others, life scientists have been slow to use social media to look for jobs or network to enhance career opportunities.  Many scientists  have  Facebook accounts but view it and other social media tools like Twitter simply as a means to stay in touch with family and friends.  However, social media can be a very powerful tool for scientists who are looking for jobs or the next big career move.

To that end, I presented a seminar at Experimental Biology this past weekend in New Orleans entitled "Social Media and Career Development for Life Sciences" that offer suggestions on how to use social media to land a job or jumpstart a career in the life sciences industry.  For those of you who may be interested, I posted the presentation below:

social media, life sciences, career development
View more presentations from cliffmz.
Until next time...
Good Luck and Good Job Hunting!!!!!

Life Scientists Should Learn To Be More Social If They Want to Find Jobs

While I was at the Experimental Biology meeting in New Orleans, LA this past week I presented a seminar entitled “Using Social Media For Career Development in the Life Sciences.” This was the first time that I presented this talk, and was expecting a large turn out given the popularity of Facebook and more recently Twitter, a microblogging platform.  Much to my surprise only 15 students showed up for the talk—many of whom hadn’t heard of Twitter and were only vaguely familiar with Facebook. Luckily, a few attendees had Facebook profiles and one or two were on Twitter so the talk wasn't a complete bust.  Nevertheless, the lack of interest in this talk was extremely puzzling to me—my other seminars, “Interviewing Tips” and “Alternate Careers for PhDs” were very well attended and I was booked solid for one-on-one resume critiquing sessions during the five days I was in New Orleans.

I started to wonder why bioscience graduate students in their mid to late 20s, many of whom will need to find jobs (postdocs otherwise) in the next few years, weren’t interested in learning how to use social media to advance their careers or conduct a job search.  I thought that the lack of interest in this topic might be explained if a majority of graduate students and postdoctoral fellows were already using Facebook, Linked In or Twitter to network or explore career opportunities. This proved not to be the case, after learning that only a small percentage of students (who sought career counseling) had considered using social media to network or look for jobs. While many had Facebook profiles, most students primarily used them to stay in touch with friends and family—not for professional or scientific purposes. 

The lack of interest in social media for career development  by many of these nascent GenY scientists was confounding. After all, I have been lead to believe that “GenY” is leading the Web 2.0 and social media charge and that aging boomers like me simply “don’t get it.” The fact that I get it and many  GenY scientists, don’t forced me to revisit what I learned about the social behavior of scientists over the past 30 years or so.

First, it is no secret that scientists aren’t the most  socially-adept individuals and when socializing it tends to be very “cliquish” and oft time exclusive.  Second, scientists are notoriously poor networkers and mostly engage in serious networking when alcoholic beverages are involved.  In other words, very little networking takes place in professional and scientific settings with the exception of  conferences and meetings. Finally, and perhaps most importantly, many of the academicians who train scientists don’t understand networking and often don’t offer any career guidance to their students and postdocs. Unfortunately, most academics have little or no understanding of the world outside of academia and, not surprisingly, there is little incentive for them to learn about it—mostly because of the anachronistic tenure system. Further, because PhDs are taught to be independent and self reliant, there is almost no emphasis placed developing social skills during their training.   In fact, many academics believe that being too social is the best way to be “scooped” by their competitors. Paradoxically, there are currently over 30 social networking sites for scientists (including BioCrowd, the career development networking site that and I started). I suspect that many of us who started these sites recognized an opportunity to use social media to bring scientists together on the Web in a less threatening way than IRL. Although several of these sites report high subscription rates, it is not clear how effective they are for networking and career development purposes.

The job market for life scientists has been extremely difficult and competitive for the past five years or so. Academic positions are still hard to come by and the recent downsizing that has taken place in the life sciences industry—about 85,000 jobs have been lost in the past three years— suggest that competition for life sciences jobs will remain fierce for the foreseeable future. Like it or not, graduate programs must begin to provide job counseling and offer career development training to their students and postdoctoral fellows—their lives may depend upon it. 

Until next time....

Good Luck and Good Job Hunting!!!!!!

 

SocialTwist Tell-a-Friend

Twitter and Pharma: Which Companies Tweet the Most?

Twitter, which is currently de rigueur in social media circles, is emerging as one of the most powerful branding and marketing social media tool that has been developed to date.   While other industries are already exploiting Twitter’s powerful marketing reach (to hawk their wares), drug makers have been reluctant to adopt Twitter and most other forms of social media. Industry analysts and company insiders contend that pharma’s reluctance to adopt social media can be attributed to the US Food and Drug Administration’s (FDA) lack of guidance on its use for promotional purposes. At present, it is anybody’s guess when this guidance may be issued, if ever.

Nevertheless, as always, there are a few daring companies willing to “boldly go where no pharma company has gone before”—in this case—Twitter! These companies include Boehringer Ingelheim (BI), Astra Zeneca, Novartis and Pfizer. According to a post on the Advance Market WoRx blog, BI is leading the way among pharma company Twitterers, with 679 following, 745 followers and 47 tweets. AstraZenecaUS has 136 following, 440 followers and 22 tweets. Pfizer has 351 following, 462 followers and 48 tweets.  Novartis has 0 following, 681 followers and 40 tweets (I guess Novartis has a thing” against following people).

Unlike its fellow pharma Twitters, BIwhich began using Twitter in November 2008—actually uses it as an interactive and conversational microblogging platform (as it was intended). The other pharma company Twitters use it almost exclusively “as a one-way PR feed” says Ellen Hoenig Carlson at Advance Market WoRx. According to a post on the Pharmafocus website, "Boehringer has incorporated Twitter into its wider communications strategy and is using the site regularly to engage its stakeholders. In addition to posting press releases, BI uses Twitter to recommend web-based information about therapeutic areas and articles that its followers might find interesting or useful. To keep its finger on the pulse of the Twitterverse, BI uses media scanning programs to help monitor online conversations and responds quickly to join in or start up Twitter conversations.”

Kudos to Boehringer for recognizing Twitter’s potential to communicate with patients, physicians and other interested parties. I hope that more pharmaceutical companies begin to use Twitter and other forms of social media to engage and improve communications with their stakeholders.

Until next time...

Good Luck and Good Twittering (or should it be Tweeting?) 

SocialTwist Tell-a-Friend

Social Media, FDA and the Life Sciences Industry

Earlier this week, the US Food and Drug Administration (FDA) sent warning letters to 14 different pharmaceutical and biotechnology companies to advise them that their approach to Internet advertising is violating federal pharmaceutical advertising and marketing guidelines and regulations. While the agency’s attempt to regulate Internet-based drug advertising is laudable, the fact that warning letters were sent to 14 different life sciences companies means that there is a poor understanding of the regulations regarding use of Internet—and more recently, social media—to market and advertise drugs, medical devices and diagnostics. This isn’t surprising because FDA has yet to issue any meaningful guidance on the use of the Internet and social media to market life sciences industry products. The reluctance of the agency to issue guidance is very puzzling—the use of web based-advertising and social media by life sciences companies has exploded in the past few years.

In a post today on the EyeOnFDA blog, Mark Sendak pointed out that Twitter is fast becoming the medium of choice for life sciences messaging, branding and product promotion. Despite FDA’s lack of guidance on the use of social media, an increasing number of life sciences companies and organizations are using it to stay in touch with their stakeholders and constituents. For example, the Juvenile Diabetes Research Foundation, the Lancet, the New Scientist, Roche, Novartis, AstraZeneca, Boehringer, Cell Therapeutics and Novartis and others have Twitter accounts. Many of these companies also have fan pages or accounts on Facebook. 

It is becoming increasingly evident that the agency will have to issue guidance on social media sooner rather than later. The wide reach, immediacy and highly interactive nature of social media suggest that the current wait-and-see attitude of FDA is no longer feasible. To jump start the discussion, Social Pharmer, a group of life sciences social media enthusiasts are holding an “unconference” in Boston on April 21, 2009. I hope that FDA sends representatives to this grassroots meeting!!!

Until next time....

Good Luck and Good Job Hunting!!!!!!!

SocialTwist Tell-a-Friend

Looking for a Life Sciences Job? Try Facebook, Twitter and BioCrowd

Using Facebook and Twitter to find jobs is becoming routine in many industries including healthcare. However, the life sciences industry is lagging behind most others when it comes to social media and recruitment. Nevertheless, many companies and academic institutions are beginning to realize that Facebook (FB), Twitter and other science social networks are good source of qualified candidates for  those difficult-to fill job openings. 

Lindsey Pollak, a GenY career guru who, writes on the use of social media for job searching, alerted me to a post (via Twitter @biojobblog) that describes how to effectively use FB to find a job.  While FB may be useful to scientist looking for work, there are many other bioscience social networks like BioCrowd (@biocrowd) that regularly post jobs and career opportunities for life scientists.

Until next time...

Good Luck and Good Job Hunting 

SocialTwist Tell-a-Friend

FDA Chides 14 Drug Makers for Misleading Internet Ads

Today's New York Times reported that the US Food and Drug Administration (FDA) issued warning letters and ordered 14 pharmaceutical and biotechnology companies to stop running what it calls misleading ads on internet search pages displayed by search engines like Google. The agency faulted the companies for failing to identify product names (brand) and not listing potential side effects (only benefits) for the drugs. In other words, the ads lacked “fair balance” something that FDA stresses and that all drug makers are very familiar with. 

Drug makers and other interest groups pay search engines like Google to place ads on search result pages after someone types in a related search word. The sidebar ads typically contain a eye-catching headline about a relevant medical condition or product and links to websites promoting certain products. The companies receiving warning letters included: Bayer, Biogen Idec, Boehringer Ingelheim, Cephalon, Eli Lilly, Forrest Laboratories, Genentech, GlaxoSmithKline, Johnson and Johnson, Merck, Novartis, Pfizer, Roche, and Sanofi-Aventis. Not surprisingly, most of the world’s largest and most profitable were guilty of running misleading Internet search engine ads.

Historically, drug companies and FDA have engaged in a cat and mouse approach when it comes to advertising and marketing drug and medical devices and diagnostics. This is because FDA’s existing regulations that guide marketing and advertising practices are relatively lax and it provides drug makers with the opportunity to see how far they can push the agency before “they get caught.” While this practice may have been acceptable for print and television advertising, it may no longer be appropriate for Internet advertising— which potentially has a much broader and larger reach than traditional media because there are not national borders on the Web. Unfortunately, FDA has been slow (reluctant?) to react to digital media and is even more perplexed about social media and the drug industry. Rather than continue to play cat and mouse, I think it would be in the best interest of consumers if FDA and drug makers would sit down and craft new guidance on regulating Internet advertising and marketing practices. It is becoming increasingly apparent that the old rules are no longer sufficient as digital and social media continue to evolve.

Until next time....

Good Luck and Good Job Hunting!!!!!!! 

SocialTwist Tell-a-Friend

 

Eye on FDA Talks with FDA's Division for Drug Marketing, Advertising and Communications (DDMAC) about Pharma, Social Media and Web 2.0

As many of you know, the life sciences industry, one of the most highly regulated industries of the economy has been hesitant and reluctant to embrace social media to reach out to patients, physicians and the lay public. This is because the US Food and Drug Administration, specifically Division for Drug Marketing, Advertising and Communications (DDMAC), has been mute on the subject and hasn’t issue one iota of guidance on the use of social media in the pharmaceutical, biotechnology or medical devices/diagnostic industries.

Mark Senak, a regulatory affairs lawyer and owner of the blog eyeonfda.com, invited Dr. Jean Ah Kang, Special Assistant at DDMAC in charge of Web 2.0 policy development to talk about FDA’s views and ideas about social media and its use in the life sciences industry. Listening to the 15 min podcast would be, according to Mark, “time well spent” for social media advocates in the pharmaceutical, biotechnology and medical devices/diagnostics sectors.

Hat tip and much “love” to Mark who wrote “BTW, I absolutely expect waves of love for this (the podcast)."

Until next time....

Good Luck and Good Listening!!!!!!!!!! 

SocialTwist Tell-a-Friend

Some Revealing Statistics About Facebook

Facebook contends that it has over 175 million members, making it the largest social network in the world! Interestingly, according to an article in today’s New York Times, most US members are “still relatively young.” “Facebook offers advertisers a target of 54.4 million members of all ages. But if an advertiser wants to narrow its target audience to those 25 or older, the number drops to 28.8 million. Narrow it to those 30 or older, and Facebook has 20.3 million to offer.” However, this is not surprisingly because people 30 and over weren’t allowed to join Facebook until 2006. In fact, many over-30 individuals have yet to sign up! In support of this, I am increasingly getting friend requests from my contemporaries—most of whom are in their 40s and 50s.

Each week, a million new members are added in the United States and five million globally—the 30-and-older group is its fastest-growing demographic (and the one with the most money to spend).  Further, Facebook members are becoming increasingly social and gregarious. In December the average number of “friends” per member was 100. Since then, it has grown to 120 per member according to a Facebook spokesperson. If Facebook continues to grow at its current rate, it will likely experience unprecedented and astonishing growth in the next few years. And, when it comes to monetizing social networks, bigger is always better!

Until next time...

Good Luck and Good Networking!!!!!!!!!! 

SocialTwist Tell-a-Friend

Connecting Scientists: What's Love Got to Do with It?

Social media is the rage these days and, by all accounts, the things that are driving it popularity are making business connections, job hunting and the opportunity to meet/connect with others on a personal/romantic level. While scientists are generally perceived as being less social than others, I believe that we, like most people, primarily join social networks for two reasons—job hunting and career development or dating and sex.

With this in mind, a quick perusal of social media sites reveals that there is no shortage of social networks specifically designed for scientists for job hunting and career development. Surprisingly, there is a dearth of sites that enable scientists to connect with one another on personal or romantic levels. This doesn’t make sense to me as someone who spent 12 years as a graduate student and postdoc. Let’s face it, we scientists generally work long hours, don’t get out of the laboratory much and generally find it hard to meet prospective mates. That is, outside of the people who we work with daily. And as I learned the hard way, workplace romances can be very tricky and uncomfortable to manage at times. But, not to worry! Yesterday, I discovered an interesting website called Science Connection—maintained and run by the Scientist.com—which was specifically designed as a “the meeting place for single science professionals and others with an interest in science or nature.” I guess you can call it match.com for scientists!

From what I could glean from its website, Science Connection was started way back in the early 1990s by “erstwhile biologist Anne Lambert, with help and advice from friends who were also biologists, birders, or science types, and with the essential involvement of her friend Roy Smith, who did the original programming.” The site boasts about 15,533 members and provides some cool stats on the number of matches, relationships, marriages and even children that resulted from members who joined the network. Most of SciCon’s members are from the United States and Canada, with small numbers from other countries and regions of the world. The scientific disciplines of its members run the gamut from physical, natural, medical and social/behavioral sciences to computers and information technology. And, some of SciCon’s members aren’t scientists but lawyers, teachers, business people, musicians and artists (science fetish?).

But, before you take the SciCon plunge, you ought to know that the average age of male members is about 49 years and for women almost 46 years. However, those averages are misleading because they were calculated from the roughly 500 members who listed their ages on their profiles. There are roughly equal numbers of men and women and the age of its members ranges from 20 to 89 years. Many members are into natural history (birding, etc.) and participate in outdoor activities.  Finally, SciCon is not a free site and annual membership is $65 (~ 18 cents/day). “The $65 annual fee buys you a list of all members of the opposite sex (what about same sex individuals?) and a monthly newsletter, which has mini-profiles, discussion forums and a place where members can announce get-togethers in their area. Member Polylogue includes in-depth analyses of cyber romance, the perils of over-50 dating and friendships that bud into romance. If the $65 annual fee is too steep a price to pay for love, then you might want to consider a three month membership which costs only $30 (~33 cents/day). However, as stated on the website, the $65 annual membership represents the “the best value.”

While I had never heard of the Science Connection before, the network has been reviewed many times in the past by a variety of media outlets that include: NPR, Newsweek (2006), Discover (2007), Forbes Magazine and others. In general, the site gets favorable reviews. That said, if I wasn’t married (my wife is lawyer) I might consider joining Science Connection. After all, it certainly beats sitting around the lab on Friday and Saturday nights analyzing sequence data—not that there is anything wrong with that!

Until next time...

Good Luck—and well, err—Good Luck

SocialTwist Tell-a-Friend

 

A Life Sciences Social Media Survey

I have been accumulating anecdotal information about companies,organizations and institutions that use social media tools like Facebook, Twitter YouTube etc.  I decided to attempt to conduct an informal survey  to determine whether or not the life sciences sector is adopting and embracing social media to meet its objectives (whatever they may be). 

To that end, I constructed a Google Docs spread sheet to collect information for the survey.  Please take a look at the survey and fill in the requested information. I will publish the results of the survey if enough people response to this request.

I look forward to hearing from as many of you as possible. Don't be shy, everything is anonymous!

Until next time...

 

Good Luck and Good Tweeting!!!!!

SocialTwist Tell-a-Friend

 

Three Ways Pharma uses Facebook

After having looked at pharma’s use of twitter, I decided to also get a feel for how pharma is engaging with facebook so far. Three main uses emerge: 1. connecting employees, 2. attracting talent and 3. promoting disease awareness or treatment adherence

1. Connecting current and ex- employees definately has the most activity. Numerous official and unofficial  groups or fan pages bring together the employees of most of the top pharma companies. For the purpose of this analysis let me concentrate the largest groups with apparent corporate endorsement (ie. use of official logo, links to company website and corporate messaging in group purpose).

Sanofi-Aventis, Novartis, Boehringer Ingelheim, Pfizer/Wyeth and Roche seem to be leading the pack in terms of activity. Sanofi and Novartis both set up official fan pages with over one thousand members. Lots of employee activism as well at  Boehringer Ingelheim, Roche, Novartis and Wyeth with facebook groups of 500+ members. (Check out this video from the official BI facebook group, just for fun).

Other, not so active groups: AstraZeneca (also have an English and French fan page), TevaGSK (French fan page), Lilly, JNJ, and Pfizer.

Interestingly, there are a number of unofficial “Pfizer“ groups expressing negative sentiment towards the company (most of it coming from layed off employees). Pfizer is also the only company that someone set up a group about them, called “conversations of Pfizer“. Not much activity unfortunately, but intersting concept nevertheless.

Another strange aside: Egytian and Turkish country groups seem to exist for basically every pharma company I researched, must be a cultural thing?

2. Regarding attracting talent, there is an overwhelming number of student, intern and training program groups for all companies; most of them probably not official. GSK seems to have the largest number of student groups, a lot of them private. Merck also stands out for its excellent Merck Careers fan page, well done, I think, but not much activity, yet.

3. Promoting disesase awareness is where I believe things finally get interesting for patients. Examples of pharma companies using facebook to drive disease awareness and treatment adherence aare not bountiful, but I did find two great examples.

The first example is the ADHD Moms group, sponsored by McNeil Pediatrics, a JNJ company. The group counts close to 8000 members, but, for me, it is not these numbers that make the group exciting. By setting up this fan page, McNeil has done a great job at creating an environment in which patients/caregivers can receive valuable information concerning treatment management and adherence, while staying within the pharma “comfort zone“.

The concept is simple. One Pediatrician and three ADHD moms, as well as “guest writers“ discuss topics of importance to raising a child with ADHD. There are polls to each topic to get the audience’s feedback, while avoiding  thorny legal issues such as adverse event reporting or off-label usage. The site also offers a podcast series and links to prominent ADHD organizaions.

The second example comes from Novartis Zometa product. It is called: Marica Strassman Takes Role as Patient Advocate. In this group, celebrity and breast cancer survivor Marcia Strassman takes on the mission to “inform breast cancer patients and caregivers about the importance of following treatment regiments outlined by their doctors “. Thus a clear focus on promoting disease awareness and treatment adherence.

The setup up is also highly transparant, clearly disclosing Zometa sponsorship with links to the Zometa homepage, product information and the facebook groupe mission:“ To educate patients with advanced breast cancer and other metastatic cancers about the risks and benefits of Zometa.“

This fan page, like the ADHD example, features links to the most prominent cancer organizations as a further resources for patients. Also, similar to the ADHD page, this site does not allow any comments from its members to prevent any legal issues.

So overall, highly encouraging signs that pharma is starting to use facebook. Most companies still seem to first experiment with more internally focused groups, but some are starting to “test the waters“ and to engage with patients on important topics like disease awareness and treatment adherence.

Silja Chouquet is the owner and CEO of whydot GmbH, an agency specialized in social media consulting, coaching and training. Her fields of expertise are the creation of patient-focused social media communications and marketing campaigns. She runs the whydotpharma blog where she discusses social media and the life sciences and other pharma-related topics.

 

SocialTwist Tell-a-Friend

Pharma and Twitter

Twitter, the microblogging platform, is the current rage in social media. According to @Shwen, who writes the Med 2.0 Blog, it grew by 752% in 2008. Shwen is a social media enthusiast who is trying to convince the life sciences industry that Twitter and other social networks can be leveraged to improve drug development and deliver healthcare.

According to a recent post on Med. 2.0, there are currently three pharmaceutical companies that are actively using Twitter: Novartis (@novartis), Boehringer Ingelheim (@Boehringer) and Astra Zeneca (AstraZenecaUS). Also, it appears that Johnson and Johnson (@JNJcomm) launched an account last week. Tweets from @novartis and @Boehringer occur fairly regularly whereas AstraZenecaUS tweets are rare. Unlike YouTube, where pharmaceutical sponsors who create channels can regulate and control content, it is much more difficult to manage Twitter because tweets are in real time, uncensored (for the most part) and can be globally disseminated within seconds.

Despite these issues, Med 2.0’s Shwen muses “I can only imagine that more pharma companies are going to be jumping on board the Twitter-train sooner rather than later. How they use it to engage, on the other hand, is going to vary greatly from company to company. At the very least, I see companies setting up accounts as “listening posts”, but others may choose to engage, like @boehringer does in an informal manner. Whatever the case, Twitter is fast becoming the new dominant space for listening and/or engaging the life sciences community.”

Like Shwen, I believe that it a matter of time before pharma and biotech realize that they must embrace social media (in all of its various forms) to remain competitive in today’s increasingly interconnected marketplace.

For those of you who may be interested, you can follow BioJobBlog (@Biojobblog) and Biocrowd (@Biocrowd) on Twitter too!

Until next time…

Good Luck and Good Twittering

 

SocialTwist Tell-a-Friend

Calling All Podcasters and PowerPoint Aficionados

We recently added a feature to BioCrowd called BioCrunch. Our goal for BioCrunch is to provide Bcrowd members with relevant, interesting and “fresh” content. Vincent and I are big fans of podcasts and PowerPoint presentations! That said, please contact me  if you are interested in contributing content for BioCrowd’s BioCrunch feature.

Until next time…

Good Luck and Good Surfing!!!!

 

BioCrowd Launches Several New Features

 As many of you know, we launched BioCrowd about six weeks ago. Our membership is steadily growing and several early members suggested changes and improvements to the site. In typical Web 2.0 fashion, we listened to those suggested and decided to add several new features!

First, we added a new section to the home page called BioCrunch. BioCrunch will feature “fresh content” developed by BioCrowd members. Items that can be posted to BioCrunch include but are not limited to podcasts, PowerPoint presentations, manuscripts and possibly poster presentations. With this in mind, we urge interested BioCrowd members to send us stuff that you wanted featured in BioCrunch and shared with the rest of the community.

Second, you can now upload multiple files with discussion posts and add a single file to comments. Also, it is now possible to preview your comment or discussion posts (before you hit the send button) to insure that they are grammatically-correct and typo-free. 

Third and perhaps most importantly, we decided to publicly open the site so that RSS feeds from BioCrowd can be imported to other social media applications including blogs, Facebook and Twitter. It also means that member profiles and discussion posts are searchable by Google. However, all posted resumes and job listings will remain private and only available to BioCrowd members, i.e. you have to join to view them.

We are planning other improvements to BioCrowd—stay tuned for new updates!

Until next time….

Join Us and Be Part of the Crowd!

 

BioCrowd Podcast: Web 2.0 and the Future of Medicine

We were able to entice Berci Mesko —a Hungarian medical student who writes at ScienceRoll and is founder of Webicina —to chat with us about the transection of Web 2.0, science and medicine.

Berci, who only sleeps four hours each night, is a medical section editor at Wikipedia, runs courses in Second Life (and real life at his medical school) and can frequently be found on Twitter enlightening his followers on topics ranging from personalized RSS feeds for physicians to the latest breakthroughs in medical genetics. While this ought to be enough for most people, Berci told us that he always wanted to be a scientist and— to realize this dream— will be entering a PhD program next fall. He is a very bright, energetic and engaging fellow whose understanding of the relationships between physicians and patients are insightful and instructive.

Have a listen and also check out BioCrowd!

Until next time…

Good Luck and Good Listening!!!

 

Big Pharma Continues to Embrace Social Media

The Eye on FDA blog reported today that AstraZeneca and Sanofi-Aventis have joined the ranks of Abbott, GSK, J&J and SanofiPasteur on YouTube. Pharmaceutical companies are taking advantage of the power of YouTube and other social media sites because regulatory guidance hasn’t been issued on its use to promote products or brand awareness. In other words, this is uncharted territory and companies can essentially 'test the waters' to see how far regulatory agencies will let them go.  I suspect that early life sciences company adopters of social media will garner substantial ROI before regulatory guidance is issued.

A lack of regulatory oversight, the ability to manage and control content and the low costs associated with creating Internet videos make YouTube and other social media sites attractive to pharmaceutical and biotechnology companies. The life sciences sector is just beginning to recognize the power of social media and the role that it may play in promoting products and brand awareness to consumers.  Expect many more life sciences companies to experiment with social media in the near future--its a veritable goldmine!

Until next time…

Good Luck and Good Video Watching!!!!!!! 

SocialTwist Tell-a-Friend

BioCrowd Founders Talk About Why They Created a Network for Bioprofessionals

For those of you who want to learn about  why Vincent and I created BioCrowd, listen to our very first podcast!   Anybody who is interested in doing a podcast for BioCrowd, please send us a note along with your ideas and when you might be available for recording the session.

Hope to see you at the Bcrowd!

 

Until next time...

Good Luck and Good Listening

Everything That You Need to Know About BioCrowd ...And Then Some!

Earlier this month, Vincent Racaniello and I launched a new social network called BioCrowd. Vincent and I created BioCrowd because we believe that social media has a critical role to play in the evolution of the life sciences and existing 'science social networks' were difficult to navigate or too broad to adequately meet the needs of the bioscience community.

Our objectives are  to promote scientific and business interactions between BioCrowd members and offer advice to members who may be seeking to advance their careers or find jobs. To that end, we decided to create a monthly podcast that will keep network members apprised of all of the comings and goings at BioCrowd.

Please send us your feedback on our very first podcast.  Also, feel free to suggest topics that you would like discussed on future podcasts! 

Until next time...

Good Luck and Good Listening!!!!!!!!! 

 

SocialTwist Tell-a-Friend

Pharma Beginning to Warm to Social Media

About a year ago, I was eating lunch and bunch of pharma executives were at the table next to me. I inadvertently overhead bits of their conversation and I heard the words, Facebook, MySpace and YouTube mentioned. This suggested to me that pharma was more aware of social media (and its business implications) than pharma publicly cared to admit. Pharma has been reluctant to embrace social media because of possible legal and regulatory ramifications. Nevertheless, a few companies have decided to boldly go where no pharma company has gone before—to YouTube.

The Eye on FDA blog, which is very bullish on social media, has been keeping aof pharma companies that have created channels on YouTube, the video site owned by Google. To date, Sanofi Pasteur, GSK, Abbot and JNJ have taken the YouTube plunge (see SanofiPasteurTV , GSKVision, AbbottChannel, andJNJHealth).  I suspect that pharma companies are willing to take a risk on YouTube, because unlike other social media platforms, they can disable the functionality that allows viewer to leave comments, kudos or kvetches after viewing videos. This shields the companies from unwarranted claims, misinformation about its products and negative publicity.

At present, the US Food and Drug Administration, has issued little or no guidance on the use of social media by drug makers. This means that drug makers are in uncharted territory and can experiment with social media without fear of much regulatory oversight or scrutiny.  Now that pharma has broken the social media barrier, I wonder whether MySpace, Facebook and Twitter (the hottest new social media tool at the moment) will be next. Interestingly, I learned yesterday that Novartis uses twitter and can be followed @Novartis.

Off the record conversations with MySpace representatives suggest that a number of pharmaceuticals have quietly created branded product pages on MySpace for years.  As the MySpace rep put it, how can you ignore an audience of 60 million people?  Further, Facebook’s fan pages are growing in popularity and don’t be surprise to see pharma pages begin to appear there. It will be interesting to see how pharma will incorporate social media into its business and marketing models in the future.

Until next time…

Good Luck and Good Video Watching!!!!!!!!

 

 SocialTwist Tell-a-Friend

Science and Social Media

Vincent Racaniello, a pioneer in RNA virology and world class researcher on the pathogenesis of polio, believes that social media can be used to enhance scientific research and improve science education. Vincent recently blogged about this on his virology blog and graciously allowed me to repost it to BioJobBlog. It is an interesting perspective from an innovative and creative scientist.

 

Science and the Social Web

In a previous post about why I blog and podcast, I discussed how these activities allow me to think more about virology and to teach far more people than I ever could in a laboratory or classroom. Is there even more value in the web for scientists?

There are three different web activities, besides blogging and podcasting that enhance science in new ways. The first is the ability to post comments on blogs and podcasts. In so doing, people can interact in ways that were not previously possible. Scientists who have never met, or students hoping to learn, all can connect and create an instructive and creative dialog. Don’t understand something in a post? Just ask. Have something different to contribute? Post it. Science can only benefit from interactions not limited by geography or time.

The second powerful web tool for science is the social networks. We know how MySpace and Facebook made it easy to meet and interact with new people. These networks also allow scientists to connect and talk about their profession. There are various groups on Facebook that enable focused, productive discussions among scientists. Even more useful are the social networks that have been developed specifically for scientists - well over 20 according to this  blog post. These networks exist to foster interactions - meeting other scientists, looking for jobs, troubleshooting experiments, finding answers to thorny questions. The value of scientific social networks is that they enable dialogue far beyond what you could achieve on your floor, in your building, by telephone or email. The result is scientific interactions at unprecedented levels.

The third web tool for scientists is Twitter. This microblogging platform restricts users to posts of 140 characters or less - the end result is concentrated information. For scientists, Twitter can be either a distraction or a gold mine. If you choose to follow individuals who are interested in science, you will, in the course of a day, find tweets with links to interesting science - news or journal articles; comments on science; questions about science or science methods - in brief, the kind of exchange originally facilitated by email but far more immediate and pithy. Follow the right people on Twitter, and receive useful information. I keep an eye on Twitter to find tips on how scientists use the web, the latest science news, and comments on science in general. In turn, when I learn of an interesting science news event or article, I tweet it. Mr. Tweet’s discussion of  the evolution of a twitter user crystallizes this concept.

There is also great value for scientists at FriendFeed. No, it’s not a fourth category - it’s an aggregator of the three activities described above, one-stop for all your blogging, podcasting, social networking, and twittering.

These three aspects of the social web are revolutionizing science. By using them, I am learning more about my field than I ever have before. Those who choose not to take advantage of the social web will miss the opportunity to become more creative and productive scientists.

 

SocialTwist Tell-a-Friend

Scientists and Social Networking

I first thought about starting a social network for life sciences professionals about a year ago after joined I Facebook and LinkedIn and then learned about SciLink, one of the first social networks for scientists. Apparently, others had the same idea and today, there are currently, by my reckoning, no fewer than 20 social networks for scientists—each promoting a unique approach to networking for scientists.

David Bradley, a UK-based science writer who can be followed on Twitter as sciencebase, did me a favor by posting a piece oh his blog in early November that reviews many of these networks. Surprisingly, most of them were designed almost exclusively for academic scientists! I was thrilled to learn this because we created BioCrowd , our new social network, for ALL life science professionals not just academicians and industry scientists. David has graciously agreed to allow me to repost his article entitled "Social Media for Scientists" below.

Social Media For Scientists

Towards the end of October, I received a flurry of emails asking me to check out new social networking sites for scientists, I’ve already reviewed the nanoscience community, of course. I suspect that, the academic year having moved into full swing, there were a few scientists hoping to tap into the power of social media tools and the whole web-two-point-ohhhh thing.

This from Brian Krueger:

“I came across your blog during my weekly Google search for “science social network.” I thought you might be interested in my website, LabSpaces.net. It’s a social network for the sciences that I’ve had on-line for the last two years and I recently got my University to send out a press release about it. I think you should stop by and check it out. Let me know what you think, I’m always looking for suggestions on how to improve the site.”

LabSpaces has all of the features of a social-networking site with the addition of a daily science newsfeed, lab profiles, a science forum, blogs, and a science protocol database. Apparently, the site provides space for researchers to create their own user profile, add their publication history, upload technical research protocols, blog about science, and share research articles with the community. The site will soon host a free video conferencing service to facilitate long distance collaborations and journal clubs.

New Zealander Peter Matthews who works in Japan emailed:

“I am a full-time researcher from NZ, working in Japan, at a museum with many international research visitors. This multilingual environment made me very aware of: (1) the difficulties that non-English based researchers face when using English, and (2) the difficulties that English mono-linguals face when trying to access or publish research in other important research languages, such as Spanish, Chinese, Japanese, French, and so on. Hence my website: The Research Cooperative - http://cooperative.ning.com. Please have a look, join if you want, and please tell any friends and colleagues about this site if you think they might find it useful.”

Pascal Boels, Managing Director of SurgyTec.com emailed with a medical tale:

“Our website is for and by medical professionals. It’s a video-sharing site for surgeons and medical professionals to show off their newly minted skills. It makes it easy for medical professionals to upload videos or slideshows and share those with the community. You can search for videos by specialty, organ/region, tissue, etiology, operation type, or technique. Many surgeons perform original and high-quality techniques in their operating room and equally many surgeons would like to learn from these new and inspiring techniques. Up till now it was very difficult, time consuming and expensive to take a look in each others operating room and share practical knowledge, tips and tricks. Surgytec.com provides the solution for this problem. We are currently serving over 4000 surgeons from more than 124 countries, sharing over 400 procedures

Priyan Weerappuli had long been interested in scientific research but felt that applied research was guarded by private institutions while basic research was held within the confines of colleges and universities by overpriced journals and an oversimplification that occurred whenever research results were translated for more general audiences. His forum/platform will attempt to open this research to a general audience - http://www.theopensourcescienceproject.com

Some correspondents are claiming they’re approaching web 3.0 nirvana:

“ResearchGATE is proud to announce a major update: We greatly improved our search functionality and called it ReFind. The name symbolizes the importance of an efficient and result-driven search functionality within research in general and within our network in particular. ReFind is one of the first search engines based on semantic, “intelligent” correlations. It enables you to find groups, papers, fellow researchers and everything else within and outside of ResearchGATE without having to read through dozens of irrelevant results. Just type a few sentences into ReFind or simply copy and paste your abstract. Our semantic algorithm will then search the leading databases for similar work, providing you with truly relevant results.” [Sounds like my Zemanta/ResearchBlogging.org idea, DB]

One observer pointed out, however, that ResearchGate’s semantic search is maybe not the greatest thing to happen to search in a decade (especially, when we have the likes of True Knowledge Ubiquity, and Zemanta. Indeed, some users have said it is not much of an improvement on conventional search.

Then there was:

“ScienceStage.com - Science in the 21st century - A wide forum for science - on an interdisciplinary, international and individual level. ScienceStage.com, the only universal online portal for science, advanced teaching and academic research, bridges a major gap in scientific research and learning. ScienceStage.com is a virtual conference room, lecture hall, laboratory, library and meeting venue all in one.”

But, perhaps the best is saved for last. An Oxford graduate student, who has completed his PhD, Richard Price, has launched Academia.edu, which he says does two things:

“It displays academics around the world in a ‘tree’ format, according to which institution/department they are affiliated with. And, it enables researchers to keep track of the latest developments in theirfield - the latest people, papers, and talks.”

Price wants to see every academic in the world on his tree and already has Richard Dawkins, Stephen Hawking, Paul Krugman, and Noam Chomsky as members. But, that’s the hype what about its potential? It resembles BioMedExperts because both use a “social” publishing tree, but is that enough to engage scientists?

It will be interesting to see whether any of these sites gain the traction their creators hope for and how things will pan out as the credit crunch bites harder. “There are a bunch of them out there,” Krueger told me, “It’s kind of scary how many came out after Nature and I went on-line in 2006. There’s definitely a lot of competition out there, it seems like a new one appears every month. I wonder how the economy and loss of tech funding is going to affect the larger start-ups.”

Then, there are those perhaps more well-known social media sites and networks for scientists, that are listed in no particular order:

Nature Network - uber network from the publishing giant

BioMedExperts - Scientific social networking

BioWizard - Blogged up Pubmed search

Mendeley - Digital paper repository and sharing

Labmeeting - Ditto

YourLabData - socialised LIMS

SciLink - Sci-Linkedin

Myexperiment.com - mostly workflows.

Laboratree.org similar to Researchgate. Not particularly social beyond groups and sharing documents with collaborators, but email is better, and arguably more secure.

scitizen.com - collaborative science news publishing

SocialMD - Med-Linkedin

Ozmosis - Ditto

DNA Network - network of DNA/genetics bloggers

ResearchCrossroads - Socialised grant databases

MyNetResearch - Socialised LIMS at a price

SciVee - YouTube for scientists (see also Watch with Sciencebase page

Scientist Solutions - science chat

There are so many, I can barely keep up, but if you have any you think I should add to the list, let me know via the comments box below. Or, more importantly, if you have used any of these systems please leave your thoughts.

Meanwhile, my apologies if you were expecting a lesson in how to use the likes of Twotter, FiendFreed, Ding, Pyuke, or Facebok’s feeble science apps, to help you get on in science socially, but I thought it was about time I did some linking out to the web 3.0 brigade in the world of science, so here they are.

Addendum: Since David published this piece in early November, BioJobBlog learned about several other social networks for scientists including labroots, beaker, scientistsolutions and wizfolio.

Until next time…

Happy Thanksgiving!!!!!!!!

 

Was the Dot-Com Bust Really a Bust?

The other day I was chatting with Tony Stubblebine of CrowdVine (the social networking company building BioCrowd for us) and I was lamenting the possible burst of the social networking bubble before BioCrowd is launched. Tony reassured me and said that “Everyone thinks that after the dot-com bubble burst that almost all Internet-based businesses failed. However, when you look more closely, you will find that this simply isn’t true—there were many survivors who were able to build robust business as the Internet matured.”  While I felt a bit better after hearing that (Tony generally knows what he is talking about) I wasn’t totally convinced that he was right. After all, I am one of his customers who are building a new social network. That said, the very next day after my chat with Tony, I found an unusually. insightful article in the New York Times entitled “Lessons of Survival, From the Dot-Com Attic.”

The authors of the article suggest that based on their analysis of existing data that 48% of dot-com companies founded in 1996 were still in business in 2004 (more than four years after the Nasdaq’s peak in March 2000 and the so called dot-com bubble burst). According to the authors, “most people are stunned by this figure: they tend to guess that about 90% of the companies failed.” Further they suggest that “the dot-com survival rate is as good as or better than that for technologies like automobiles, tires and televisions during their formative years.”

How did the dot-com survivors do it? Instead of trying to a make a big splash in high profile market sectors, they identified niche markets that didn’t offer ROIs of hundreds of millions of dollars returns but represented viable Internet-based, business opportunities that could flourish if nurtured correctly. This largely assuaged most of my concerns about a possible impending social network bubble bust and proved to me that Tony knows his stuff! So, whether or not the social network bubble is going to burst, BioCrowd will be launched and we hope that like any new member of a species that it will be strong and fit enough to survive! 

Until next time.

Good Luck and Good Job Hunting!!!!!!!

 

 

BioCrowd-Beta Is Ready For Launch

I want to let my readers know that a beta-version of BioCrowd is ready for review. For those of you who may not know about BioCrowd, it is a social network for life sciences students and professionals that was created by Vincent Racaniello a Professor at Columbia University College of Physicians and Surgeons and me. 

The reason we started BioCrowd was that Vincent and I both perceived a need for undergraduate and graduate students and postdoctoral fellows to more effectively network with established scientists and life sciences professionals to further advance their careers or find jobs. The social interactivity of Facebook and the business connectivity of LinkedIn are what led to the creation of BioCrowd.

We are looking for a few brave women and men who want to help to beta-test BioCrowd before we launch.  If you are interested, please visit us at www.biocrowd.com and drop us a line.   For those of you who don't want to participate at the moment, but want to learn about our progress, you can follow us on Twitter and FriendFeed ,

Until next time...

 

Good Luck and Good Job Hunting!!!!!!!

Using Twitter to Find That Next Job

I never truly understood the power and reach of Twitter until I caved in and started using it about a month ago. Over the past couple of weeks, I realized that Twitter is an ideal tool for networking and job hunting. Apparently, I am not alone. Miriam Salpeter from Keppie Careers has graciously agreed to shares some tips on using Twitter to help you search for a Job. Follow Miriam on Twitter @Keppie_careers

Tweeting Your Way to a Job

Would you believe that you can tweet yourself to a job opportunity 140 characters at a time? It’s been done! Statistics show that job search networking is much more effective when you make “loose” connections - touching base with people beyond your immediate circle whose networks and contacts are much different from your own. With over 3 million users, Twitter offers an unparalleled opportunity to create an extended network.

Not convinced that Twitter is actually a high-powered job search tool? Read on to learn how Twitter can uniquely position you for job-hunting success!

What Can Twitter Do For You?

  1. Afford access to other professionals in your field. When you follow industry leaders, you’ll know who spends time with them, what conferences they attend (and what they think of the speakers!), what they’re reading and what is on their minds. This is great information to leverage for your search.
  2. Provide exposure and credibility as well as personal and professional relationships when you connect to others in your industry.
  3. Offer you a venue to demonstrate your expertise and share information in quick, pithy bursts of wisdom. This is perfect if you don’t have the time or energy to create a blog.

Unique Aspects of Twitter

  1. It is casual and immediate and a great place to “meet” informally.
  2. You’ll find an array of people on Twitter, including CEOs, top-level executives, hiring managers, recruiters and everyone in-between! It’s one-stop shopping for your networking needs. You’ll be surprised to find that stars in your field (mentors) may follow you if you reach out to them!
  3. Unlike Facebook, where it is kind of creepy if you start trying to “friend” people who are connected to your contacts, it is acceptable (and expected) to follow people on Twitter because another friend or colleague does.
  4. It forces you to be brief. Coming up with your “Twit-Pitch” - what you have to offer in 140 characters or less - will help you clarify your value proposition. Remember: less is more!

 

 It Really Does Work!

  1. Kyle Flaherty used Twitter to find a job that moved him and his family to Austin, TX from Boston. He tweeted to approximately 650 contacts that he had left his job. He included a link to a blog post outlining his interest in connecting. He explains, “Within hours I had several emails, IMs, phone calls and tweets about the topic and it actually ended up that I took a new job.” Follow this link for an interview with Kyle’s new boss, Pam O’Neil, who explains how she and Kyle used Twitter to fill the position.
  2. Heidi Miller, the “Podcasting Princess,” found a freelance project using Twitter by tweeting updates about her job hunt. Many of her colleagues questioned the wisdom of being so open about her search; they worried she look desperate or foolish. However, the ends justified the means.

As more and more get involved (dare I say addicted?) to Twitter, opportunities to leverage this tool for job search networking will grow exponentially. Don’t be the one left behind! Get on board and start connecting for success!

 

Twitter: What Is It Good For?

 Because I am trying to become a social network maven (and I wanted to be cool), joining Twitter was a no- brainer.  I have used Twitter for over two months now and I still haven’t figured out why people use it. I frequently post Twits or Tweets (whatever they are called) and I rarely get any responses, even when I direct the questions to some of my followers. Would somebody out there be so kind as to tell me what I am doing wrong or how to use Twitter correctly?

BTW, my new Twitter nick is: BioJobBlog—please follow me and make a social networking neophyte very happy!

Until next time….

Good Luck and Good Job Hunting!!!!!!!!

 

Social Networking and Scientific Research

Over the past year or so, social networking has taken the Internet by storm. This is largely  because social networking software purveyors like CrowdVine and Ning have provided out-of-the-box solutions that allow people to easily create social networks that strike their fancy. That said, will the advent of social networks do anything more than allow musicians to sell records or provide an easy place for people to hook up? To that end, Jessica a regular BioJobBlog reader sent me a story (see below) about a survey that was performed to gauge the possible impact of social networking on scientific research.

Social Applications to Play Deeper Role in Future Research

The future of social media will not just build friendships but support groundbreaking scientific discoveries.

Scientists and researchers are using social media… but mostly for professional reasons. A recent survey from 2collab reveals that over half of science, medical and technical information specialists working in academia and government institutions believe social networking will play a key role in shaping the future of research. Additionally, the study suggests tomorrow’s university faculty (respondents aged 25 - 44 in academic research positions who have published 1-10 articles) are already heavily using social media and are eager for the applications to be further developed for use in their work.

According to the survey which included 1,800 respondents, the top areas where social applications will have a major influence on research in the next five years include:

1.      Professional networking and collaboration (34.4%)

2.      Career development (26.4%)

3.      Critical analysis and evaluation of research data (25.3%)

4.      Dissemination of research output (24.5%)

5.      Conducting primary research (23.4%)

6.      Grant application and funding (22.7%)

Much to my delight, the results from the survey confirmed my belief that social networking among scientists would stimulate and be a boon to scientific research. This strengthened my conviction to move forward with the bioscience networking site, BioCrowd, that Vincent Racaniello and I plan to launch by the end of September, 2008. Rumor has it that their may be gifts for the first 100 people who join after launch.

So, don’t wait and become part of the BioCrowd today.

Until next time….

Good Luck and Good Social Networking (it will help you get a job!)

GlaxoSmithKline is the Next Big Pharma Company to Embrace Social Media

It was only a matter of time after J & J launched its health channel on YouTube two weeks ago, that other pharma companies would begin to post videos on video-sharing sites. As a general rule, nobody in pharma wants to be first but after the first company takes the plunge, nobody wants to be left out or behind. Therefore, it came as no surprise when late last week, GlaxoSmithKline (which has a tendency to be second-to-market with competing products), launched a beta version of it so-called GSKCIC channel on You\Tube.

 According to a post on the Pharmalot blog, so far there are only two videos on the channel. One describes the company ongoing commitment and fight against disease in the developing world (ironically, the video ends prematurely).The second, which is full length, features CEO Andrew Witty telling us about his career at GSK (which began in 1985 as a management trainee) and how GSK is looking for a few good employees who “like a good challenge.” Curiously, the day after the Witty video appeared on YouTube, GSK announced that it was laying off about 90 workers or 10% of its work force at its manufacturing plant in Zebulon, North Carolina. A company spokesperson said that more cuts are expected at the North Carolina facility.

Maybe someone at GSK ought to tell its CEO that the company isn’t hiring at the moment?????????

Hat tip to Ed at Pharmalot!

Until next time….

Good Luck and Good Job Hunting!!!!